<?xml version="1.0" encoding="UTF-8"?>
<p id="para0008">Cell- and tissue-based products that are not substantially manipulated and intended to be used for the same essential function are usually considered cell or tissue transplants, as in the case of hematopoietic stem cell transplantation; or they are considered transfusion medicine, as in the case of adoptive cellular immunotherapy to prevent relapse in patients with leukemia who are infused with donor lymphocytes. Donation, procurement, testing, processing, preservation, storage, distribution, traceability and coding of human tissues and cells for transplantation have to comply with the requirements and standards of quality and safety set out in several European directives [
 <xref rid="bib0019" ref-type="bibr">[19]</xref>, 
 <xref rid="bib0020" ref-type="bibr">[20]</xref>, 
 <xref rid="bib0021" ref-type="bibr">[21]</xref>, 
 <xref rid="bib0022" ref-type="bibr">[22]</xref>]. Similarly, collection, testing, processing, storage, distribution and traceability of human blood and blood components for transfusion have to comply with standards of quality and safety regulated at the European level [
 <xref rid="bib0023" ref-type="bibr">[23]</xref>, 
 <xref rid="bib0024" ref-type="bibr">[24]</xref>, 
 <xref rid="bib0025" ref-type="bibr">[25]</xref>].
</p>
